COVID Pills and Drugs

Larry A. Law

​With the truth about the ineffectiveness and dangerous side effects of COVID-19 experimental injections slowly coming out, new drug therapeutics have been encouraged. Old, tried and true, inexpensive drugs like Ivermectin and hydroxychloroquine have higher rates of effectiveness and superior safety profiles. These older drugs were smeared so that new money could flow unimpeded to the pharmaceutical industry and to Dr. Fauci. It turns out that the new drugs developed for fighting COVID-19 have been disasters. I will provide a little background on these latest ones: Remdesivir, Paxlovid, and Molnupiravir. 

Gilead's Remdesivir

​Remdesivir is the primary drug authorized by the government for COVID treatment. The U.S. government pays hospitals a 20% upcharge for sticking with the remdesivir protocol, plus an additional bonus. Hospitals have to use remdesivir if they want to qualify for liability protection (not be sued for drug injury). The drug routinely causes severe organ failure and, often, death. In fact, some nurses refer to the name of the drug, remdesivir as “Run Death is Near.” Incredibly, in late April 2022, the Food and Drug Administration (FDA) approved remdesivir as the first and only COVID-19 treatment for children under 12, including babies as young as 28 days! Even worse, the drug is now also approved for outpatient use in children. This is very disturbing as serious liver inflammation and kidney failure can regularly occur. Six months into an Ebola study, the trial's Safety Review Board suddenly pulled remdesivir from the trial. Within 28 days, subjects taking remdesivir experienced lethal side effects including multiple organ failure, renal (kidney) failure, septic shock, and hypertension. 54% of the remdesivir group died! 

WHO Recommendation Against Remdesivir

​Dr. Meryl Nass expressed her concerns by stating that the “WHO recommended against the drug (remdesivir) on November 20, 2020. Few, if any, other countries used it for COVID apart from the United States. A large European trial in adults found no benefit. The investigator felt 3 deaths were due to remdesivir (0.7% of subjects who received it). However, on April 22, 2022 the WHO recommended the drug for a new use: early outpatient therapy in patients at high risk of a poor COVID outcome.” Dr. Nass also stated, “When we look at the press release issued by Gilead (manufacturer for remdesivir), we learn the approval was based on an open label, single arm trial in 53 children, 3 of whom died (6% of these children died); 72% had an adverse event, and 21% had a serious adverse event.” This seems like an extremely risky treatment choice for young children, especially since children rarely get COVID and when they do, they recover at over a 99.98% rate. One has to wonder why the safe and effective monoclonal antibody treatment centers have been turned into outpatient remdesivir centers by the government. 

Pfizer's Paxlovid Pill

​Another drug in the news is Paxlovid. It is manufactured by Pfizer. COVID patients treated with a 5-day course of Paxlovid sometimes experience a severe rebound when the medication is withdrawn. David Ho, a virologist at the Aaron Diamond AIDS Research Center at Columbia University documented his own rebounding experience. Ho said he came down with COVID, was prescribed Paxlovid, symptoms dissipated and tests turned negative. But ten days after getting sick, the symptoms returned for 2 more days and his tests turned positive. Because he is a virologist, he was able to sequence his own virus and prove that it was from the same strain (it had not mutated). A second family member also got sick and experienced similar rebound symptoms. Ho hypothesized that a small proportion of virus-infected cells may remain viable after treatment with Paxlovid. The infected cells resume pumping out viral progeny (children) once treatment stops. This rebounding effect was not documented on the label but occurs often and is very disconcerting. 

Paxlovid and Anthony Fauci

Dr. Fauci experienced the same rebounding effect in mid-June. Fauci tested positive for COVID-19 on June 15 despite being quadruple-vaccinated. Because he is 81 years old, he was prescribed Paxlovid even though his symptoms were initially mild. He stated, "After I finished the five days of Paxlovid, I reverted to negative on an antigen test for three days in a row. And then on the fourth day, just to be absolutely certain, I tested myself again. I reverted back to positive. It was sort of what people are referring to as a Paxlovid rebound." He reported that the next day he began to feel "really poorly" and "much worse than in the first go-around." Dr. Fauci is the head of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to President Biden. He gave and wasted $10.5 billion of US taxpayer money to Pfizer for a drug that doesn't work. 

Merck's Molnupiravir

​Molnupiravir developed by Merck and Ridgeback Therapeutics also has side effect concerns including cancer and birth defects. Dr. William Haseltine, Ph.D., a former professor at Harvard Medical School, reported in a November 2021 article published in Forbes his concerns about the drug: “My concern with molnupiravir is because of the mechanism by which this particular drug works. Molnupiravir works as an antiviral by tricking the virus into using the drug for replication, then inserting errors into the virus’ genetic code once replication is underway. When enough copying errors occur, the virus is essentially killed off, unable to replicate further… But my biggest concern with this drug is…molnupiravir’s ability to introduce mutations to the virus itself that are significant enough to change how the virus functions, but not so powerful as to stop it from replicating and becoming the next dominant variant.” Haseltine told Newsweek that, “Of all the antiviral drugs I have ever seen, this is by far the most potentially dangerous… The more people that take it, the more dangerous it will be.” With drugs like this, is it any surprise that COVID-19 mutates so much?

Bottom Line

​The fact that government health officials have focused on these drugs to the exclusion of all others is evidence of the powerful influence of the pharmaceutical industry. Ivermectin is extremely effective against COVID and has been shown to outperform at least 10 other drugs including Paxlovid. It costs on average only $58 for 20 pills of treatment. Paxlovid costs $529 for a 5-day course of treatment. Molnupiravir costs about $700. Remdesivir costs $2340 for 5 days of treatment ($4680 for 10 days). Paxlovid alone has cost U.S. taxpayers $10.5 billion. The FDA and CDC are governmental regulatory agencies more aligned with the pharmaceutical industry than with the public. They were supposed to protect us. Since they are not looking out for us, it is imperative for individuals to take personal responsibility for their health. Do your own research. Early treatment protocols exist for COVID and all respiratory viral infections, but they are not sponsored by the CDC or even most hospitals. Learn how to protect yourself and those you love.